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ORIGINAL ARTICLES—Laboratory science
Adhesion molecules in iris biopsy specimens from
patients with uveitis
Ellen La Heij, Robert W A M Kuijpers, Seerp G Baarsma, Aize Kijlstra,
Marcel van der Weiden, Cornelia M Mooy
Abstract
Background/aims—Earlier studies on in-
traocular tissue have demonstrated that T
lymphocytes play a major role in the
pathogenesis of uveitis. Adhesion mole-
cules are immunoregulatory molecules
for the interaction between T lymphocytes
and vascular endothelium and they play
an important role in the recruitment of
specific T lymphocytes from the circula-
tion into inflamed tissue. In uveitis an
increased expression of some of these
adhesion molecules may be expected.
Methods—The presence of adhesionmole-
cules was investigated in iris biopsy speci-
mens from 11 patients with uveitis and
eight controls (patients with primary open
angle glaucoma) immunohistochemically
with a panel of monoclonal antibodies:
LECAM (CD 62L), ICAM-1 (CD 54),
LFA-1 (CD 11a/18), VCAM-1 (CD 106),
VLA-4 (CD 49d), and HECA-452, a
marker for high endothelial venules.
Results—Positive staining for ICAM-1,
LFA-1 and VCAM-1 was found in the iris
in a significantly higher number of uveitis
patients than in controls. The remaining
adhesion molecules were also found in a
higher number of uveitis patients than in
controls, but this diVerence did not reach
statistical significance.
Conclusion—An increased expression of
adhesion molecules was found in the iris
of patients with uveitis, indicating an
immunoregulatory function for adhesion
molecules in the pathogenesis of uveitis.
(Br J Ophthalmol 1998;82:432–437)
In most types of uveitis the aetiology is still
unclear. In the past 10 years immunohisto-
chemical studies on intraocular tissue, and the
detection of inflammatory mediators in aque-
ous humour and vitreous, have revealed some
mechanisms in the pathogenesis of uveitis. It
was demonstrated that the cellular infiltrate in
iris specimens obtained from patients with dif-
ferent types of uveitis consisted primarily of T
lymphocytes, with a minimal B cell and plasma
cell infiltrate.1–4 Most of these T lymphocytes
and even iris resident cells were HLA-DR
positive. Also in animal models with experi-
mental uveitis a predominantly T lymphocytic
infiltrate was found.5 A delayed type of
hypersensitivity (type IV) immune mediated
pathogenesis was therefore suggested for
uveitis.1
Adhesion molecules are important regula-
tory molecules for T lymphocytic functions
outside the bloodstream and in inflamed
tissues. They play a critical role in immunosur-
veillance and mediate interactions between T
cells and vascular endothelium, and T cells and
extracellular matrix.6 Originally, adhesion mol-
ecules were discovered as lymphocyte homing
receptors, involved in the entrance of lym-
phocytes from the blood circulation into
lymphoid tissue via postcapillary venules with
specialised endothelium. These so called high
endothelial venules (HEV) express specific
surface proteins (vascular addressins) in a
tissue specific manner. In the subsequent
years, many of these surface proteins have been
identified and until now five structural families
of adhesion molecules have been described:
selectins, integrins, the immunoglobulin super-
family, mucins, and cadherins. They play an
essential role in the process of inflammation
and recruitment of active and specific T cells
and other leucocytes into inflammatory tissue.
A multistep model of sequential leucocyte
endothelial cell interactions has been
proposed.7 8 The initial steps, after activation of
the endothelium, are mediated to a large extent
by selectins resulting in a “rolling and tether-
ing” of the leucocyte to the vessel wall. The
second step involves activation of T cell adhe-
siveness by chemokines (monocyte chemo-
attractant proteins (MCP) 1, 2, 3, macrophage
inhibitory proteins 1á and 1â, RANTES). The
third step comprises stable arrest and firm
adhesion of the lymphocyte to the endothe-
lium. This is mediated by integrins on the sur-
face of the T cell and immunoglobulin
superfamily (IgSF) adhesion molecules on the
endothelial cells. Cytokines such as TNF-á,
IL-1, IL-4, and IFN-ã strongly upregulate
their expression.6 The fourth step, leucocyte
diapedesis, is still poorly characterised; it is
likely that integrin-IgSF interactions play an
important role.6 As extracellular matrix com-
ponent, fibronectin has been demonstrated to
interact with integrins resulting in T cell
proliferation.6
Br J Ophthalmol 1998;82:432–437432
Department of
Ophthalmology,
University Hospital
Rotterdam, Dijkzigt,
Netherlands
E La Heij
R W A M Kuijpers
C M Mooy
Department of
Pathology, Erasmus
University Rotterdam,
Netherlands
M van der Weiden
C M Mooy
Eye Hospital
Rotterdam,
Netherlands
S G Baarsma
Netherlands
Ophthalmic Research
Institute Amsterdam,
Netherlands
A Kijlstra
Correspondence to:
Dr E La Heij, Academisch
Ziekenhuis Maastricht,
Postbus 5800, 6202 AZ
Maastricht, Netherlands.
Accepted for publication
6 November 1997
 on 11 December 2006 bjo.bmj.comDownloaded from 
The multistep adhesion cascade of distinct
classes of T cell interaction with endothelium,
their activation and subsequent transmigration
into the extracellular matrix is accompanied by
a diVerential expression of adhesion molecules
and cytokines in a tissue specific manner. The
eye is known to be an immunologically
privileged site9 and it may be expected that an
intraocular homing receptor or a specific com-
bination of adhesion molecules contributes to
the immunosuppressive properties of the ante-
rior segment of the eye. In uveitis there may be
a disturbance of this phenomenon of anterior
chamber associated immune deviation10
(ACAID) and diVerent adhesion molecules
and cytokines may play a role.
Adhesion molecules have been demon-
strated in the eyes of patients with uveitis,11 12
and are also found in other tissue sites involved
in autoimmune diseases (synovium in rheuma-
toid arthritis and skin lesions in psoriasis).13 14
In an animal model,15 adhesion molecules are
expressed before histological evidence of in-
flammation, and may therefore be important
targets for selective immunotherapies.
We investigated the presence of several
adhesion molecules involved in diVerent steps
and acting at various moments in the adhesion
cascade in the iris of patients with uveitis
versus controls (that is, iris from patients with
primary open angle glaucoma).
Materials and methods
IRIS BIOPSY COLLECTION
Iris biopsy specimens (from peripheral iridec-
tomies) were obtained from 11 patients (four
men and seven women) with uveitis during
cataract surgery or trabeculectomy. Their
mean age was 60 years (range 27–88 years).
Iris biopsy specimens from eight patients (five
men and three women) with primary open
angle glaucoma, obtained during trabeculec-
tomy served as controls. Their mean age was
68 years (range 28–83 years).
The diagnosis of uveitis was made according
to the criteria suggested by the International
Uveitis Study Group.16 Three patients had
Fuchs’ heterochromic cyclitis, one had recur-
rent anterior uveitis associated with HLA-B27,
and seven patients had chronic idiopathic uvei-
tis (four with anterior uveitis and three with
panuveitis, one of whom had a positive
mantoux test). At the time of operation the eye
was quiet in all cases. Because of the risk of
increased inflammation after surgery, uveitis
patients are often operated on only during a
quiet phase of their disease established by a
long preoperative period of anti-inflammatory
medication. Moreover, biopsies are not ob-
tained as a procedure to make the diagnosis,
which is the case in aqueous humour or
vitreous analysis, in which material may be
obtained during an active stage of the disease.
None of the uveitis patients received systemic
anti-inflammatory or immunosuppressive
treatment, but five were treated with local ster-
oids and/or NSAIDs, and seven were using
local antiglaucoma medication. The diagnosis
of primary open angle glaucoma (POAG) was
made on the following criteria: (a) open angle
on gonioscopy; (b) elevated intraocular pres-
sure (>21 mm Hg) with or without antiglau-
coma medication; (c) presence of glaucoma-
tous visual field defect(s) and/or optic disc
damage; and (d) no signs of intraocular
inflammation. None of the patients with
glaucoma was treated with systemic or local
anti-inflammatory medication, but all received
antiglaucoma drops at the time of the opera-
tion. We chose patients with POAG as a
control group without clinical evidence of
inflammation rather than patients undergoing
extracapsular cataract extraction for age re-
lated cataract, because peripheral iridectomy is
an integral part of trabeculectomy. All patients
were informed and their consent was obtained.
HISTOPATHOLOGICAL INVESTIGATION
One frozen section from each specimen was
stained with haematoxylin and eosin to evalu-
ate the following pathological features: (1) the
appearance of a mononuclear cell infiltrate; (2)
the presence of high endothelial venules with
cuboidal vascular endothelial cells; (3) hyalini-
sation of the vessel walls; (4) iris stroma
atrophy and fibrosis; (5) focal depigmentation
of iris pigment epithelium; and (6) the
disappearance of stromal melanocytes.
IMMUNOHISTOCHEMICAL TECHNIQUE
All specimens were snap frozen in OCT (opti-
mal cutting tissue) compound within 1 hour of
iridectomy. Cryostat sections 4 µm thick were
air dried and subsequently fixed in formalin
4% for 10 minutes17 and were subsequently air
dried and rinsed in phosphate buVered saline
(PBS) solution (pH 7.4). In order to conserve
the morphology of the frozen tissue sections,
we tested formalin fixation of frozen tissue sec-
tions for only 10 minutes, analogous to a
method described earlier.17 In our positive con-
trols (lymphoid tissue) there were no artefac-
tual staining results or destruction of antigens
comparing short formalin fixation and acetone
fixation.Moreover, for all monoclonal antibod-
ies, positive and negative controls were tested
to determine the optimal concentration of the
monoclonal antibodies that had to be applied
to the iris biopsies, to ensure that as with the
other steps of the immunohistochemical proce-
dures, no artefacts were induced.
Slides were then incubated with 10% normal
goat serum in 1% PBS/BSA (bovine serum
albumin). After this step, they were incubated
for 30 minutes at room temperature (20°C)
with a panel of monoclonal antibodies (Table
1) in 1% PBS/BSA solution. After rinsing in
PBS, slides were incubated for 30 minutes at
room temperature with biotinylated multilink
immunoglobulin 1:50 (Biogenex, San Ramon,
USA) in 1% PBS/BSA, and after rinsing with
PBS, with streptavidin labelled alkaline phos-
phatase. Subsequently, slides were thoroughly
washed in PBS and TRIS-HCl (pH 8.0), and
antibody antigen binding was demonstrated
using the substrate naphthol-as-mx phosphate
(Sigma, USA). Levamisol was added to inhibit
endogenous peroxidase and phosphatase. Sec-
tions were counterstained withMayer’s haema-
toxylin to obtain a discrete nuclear staining
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pattern. Positive reactions produced a red col-
our, which made diVerentiation from dark
brown endogenous melanin possible. Omission
of the monoclonal antibodies served as nega-
tive control.
SCORING SYSTEM AND STATISTICAL ANALYSIS
Tissue sections were examined using a 25× and
40× magnification by two independent observ-
ers, both of whom were unaware of the diagno-
sis. Vascular endothelium, iris resident cells
(stromal melanocytes, iris pigment epithelial
cells, fibroblasts, and endothelium), and
mononuclear cells were scored separately. A
semiquantitative scoring system was used with
a scale ranging from zero (-) to 4+ according to
the intensity of staining of positive cells. The
Fisher’s exact test was used to compare the
incidence of positive staining (in which only
specimens graded as 1+ or more were consid-
ered) between specimens from patients with
uveitis and patients with glaucoma.
Results
HISTOPATHOLOGICAL EVALUATION
Scattered deposits of infiltrating mononuclear
cells, mainly lymphocytes, were seen in haema-
toxylin and eosin stained sections in 10 out of
the 11 iris biopsy specimens from patients with
uveitis. A few isolated mononuclear cells were
also seen in two of the eight iris biopsy
specimens from patients with glaucoma. These
were also the only two cases in which an
expression of adhesion molecules was found
(see below). In the iris of patients with uveitis
no evident perivascular accumulation of lym-
phocytes was observed, nor were lymphocytes
found in the vessel walls. Pathological features
typical of Fuchs’ heterochromic cyclitis22 were
observed in one of the three iridectomies from
patients with Fuchs’ heterochromic cyclitis:
hyalinisation of the vessel walls, iris stroma
atrophy and fibrosis, focal depigmentation of
iris pigment epithelium, and the disappearance
of stromal melanocytes. Some degree of
hyalinisation of the vessel wall was observed in
two iris biopsy specimens from patients with
uveitis, but not in iris biopsies from glaucoma
patients. No morphological features of high
endothelial venules were observed in any of the
patients.
ADHESION MOLECULE EXPRESSION IN UVEITIS
PATIENTS
The expression of adhesion molecules in iris
biopsy specimens from patients and controls is
summarised in Table 2. Because there were
only very small diVerences in intensity of the
Table 1 Monoclonal antibodies used, function, and family of the adhesion molecules
Monoclonal antibody/receptor
Specificity,
dilution, clone Source Family Expression, function6 18–20 Ligand20
LECAM, L-selectin, CD
62L
IgG, 1:75,
mouse, clone
FMC46
Dako, Denmark Selectin family Expressed on most peripheral blood leucocytes.
Shed after activation. Involved in adhesion of
neutrophils, eosinophils, monocytes to
endothelium. Mediates initial rolling and
tethering of leucocytes to endothelium.
GlyCAM-1, CD34,
sialyl-lewis x
ICAM-1, CD 54 IgG, 1:25,
mouse, clone
1H4
Neomarkers,
Fremont USA
Immunoglobulin
superfamily
Expressed on resting endothelial cells, epithelial
cells, mononuclear cells, fibroblasts.
Upregulated by IL-1, TNF, and IFN-ã.
Mediates firm adhesion and transmigration of
lymphocytes to endothelium, and interaction
between T cell and extracellular matrix.
LFA-1, MAC-1,
CD43
LFA-1â-chain; CD18,
LFA-1á-chain; CD11a
IgG, 1:120,
mouse, clone
NHM23 IgG,
1:800, mouse,
clone NHM24
Dako, Denmark â2 Integrins, Expressed on peripheral blood lymphocytes,
neutrophils, and monocytes. Mediates adhesion
of leucocytes to endothelium.
ICAM-1,-2,-3
VCAM-1, CD 106 IgG, 1:25,
mouse, clone
1.4C3
Dako, Denmark Immunoglobulin
superfamily
Expressed on activated endothelium, after
upregulation by IL-1, TNF-á, IL-4. Also
expressed on macrophages and dendritic cells.
Involved in lymphocyte homing and
recruitment to sites of inflammation. Mediates
firm adhesion of leucocytes to endothelium.
VLA-4, á4â7
VLA-4, CD49d IgG, 1:10,
mouse, clone
44H6
Serotec, UK â1 Integrins Expressed on leucocytes, monocytes, and
eosinophils. Mediates adhesion and
transmigration of leucocytes to activated
endothelium.
VCAM-1, fibronectin
(extracellular matrix)
HECA-452, monoclonal
antibody against high
endothelial venules
IgM, 1:500, rat Gift from Dr
Duijvenstijn,
(University of
Limburg,
Netherlands)
Expressed on activated endothelium, involved
in homing of lymphocytes to lymphoid tissue.
Expressed on endothelium specialised in highly
increased lymphocyte extravasation to sites of
severe inflammation.21
sial-lewis x
LECAM= leucocyte endothelial cell adhesion molecule; ICAM-1 = intercellular adhesion molecule-1; LFA-1= lymphocyte function associated antigen 1; VCAM-1=
vascular cell adhesion molecule-1; VLA-4 = very late antigen-4; HECA-452 = monoclonal antibody against high endothelial venules.
Table 2 Expression of adhesion molecules in iris biopsy specimens from patients with
uveitis or glaucoma
Adhesion molecules Uveitis (n=11) Glaucoma (n=8) p Value†
Vascular endothelium
ICAM-1 10/11 (91%) 2/8 (25%) 0.0062
VCAM-1 4/11 (36%) 2/8 (25%) 0.49
HECA-452 3/7 (43%) 1/8 (12.5%) 0.23
Iris resident cells*
LECAM 0/11 0/8 1.0
ICAM-1 11/11 (100%) 2/8 (25%) 0.0013
LFA-1á 6/11 (55%) 0/8 0.017
LFA-1â 1/11 (9%) 0/8 0.6
VCAM-1 7/11 (64%) 0/8 0.013
VLA-4 1/8 (12.5%) 0/8 0.58
Infiltrating mononuclear cells
LECAM 0/11 1/8 (12.5%) 0.42
ICAM-1 11/11 (100%) 2/8 (25%) 0.0013
LFA-1á 5/11 (45%) 1/8 (12.5%) 0.15
LFA-1â 1/11 (9%) 1/8 (12.5%) 0.68
VCAM-1 6/11 (55%) 2/8 (25%) 0.21
VLA-4 1/8 (12.5%) 2/8 (25%) 0.5
*Iris melanocytes, iris pigment epithelial cells, fibroblasts.
†Fisher’s exact test, without correction for multiple comparisons.
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staining and the number of positive cells
between the various uveitis patients, we only
depicted in how many specimens positive cells
(1+ or more) were found. Four specimens were
excluded from analysis because they were too
small. Moreover, as can be seen in Table 2
instead of 11 uveitis patients tested for HECA-
452 only seven tissue sections of the biopsies
gave a reliable score, and with VLA-4 only
eight out of 11 gave a reliable score. The
expression of ICAM-1 (on vascular endothe-
lium, iris resident cells, and on infiltrating
mononuclear cells), of LFA-1á (on iris resident
cells), and of VCAM-1 (on iris resident cells)
was found in a significantly higher number of
iris biopsies from patients with uveitis than
from patients with glaucoma (Table 2). No dif-
ference in the expression of any of these adhe-
sion molecules was observed between patients
with Fuchs’ heterochromic cyclitis and other
uveitis entities. No evident correlation was
found between those patients treated with local
steroids and/or antiglaucoma medication at the
time of operation, and the presence or absence
of adhesion molecules.
Anti-LECAM (CD 62L) showed a positive
staining in only one iris from a patient with
glaucoma. Anti-ICAM-1 (CD 54) yielded the
highest positive scores; staining with vascular
endothelium in 10 out of 11 iris biopsies from
patients with uveitis and with iris resident cells
and infiltrating mononuclear cells in all cases
(Fig 1A). Anti-LFA-1á (CD 11a) antibody
reacted with iris resident cells and mononu-
clear cells, but not with vascular endothelium
(Fig 1B). In some cases a few LFA-1á positive
mononuclear cells surrounded blood vessels
that were ICAM-1 positive. Anti-LFA-1â (CD
18) showed staining of iris resident cells and
scattered mononuclear cells in only one patient
with uveitis. VCAM-1 reacted positively with
vascular endothelium in four out of 11 patients
with uveitis, but also with iris resident cells and
infiltrating mononuclear cells in seven and six
out of 11 patients with uveitis, respectively (Fig
1C). Anti-VLA-4 (CD 49d), functionally the
receptor for VCAM-1 and fibronectin, stained
only few resident cells and infiltrating mono-
nuclear cells in the iris of one patient with
Fuchs’ heterochromic cyclitis. HECA-452, a
Figure 1 Light microscopic images (original magnification × 400) of immunohistochemistry giving a red (positive)
staining result. Some of the iris resident cells (open arrows), infiltrating mononuclear cells (closed arrows), and a lumen of
an iris vessel with a lining of endothelial cells (star) have been marked in the figures. Staining with (A) anti-ICAM-1 and
(B) anti-LFA-1á in a patient with Fuchs’ heterochromic cyclitis, and (C) anti-VCAM-1 in a patient with anterior uveitis
of unknown origin, (D) negative control (original magnification × 250); patient with uveitis, in which all steps of the
immunohistochemical technique were applied, except for the specific monoclonal antibodies. These were omitted to
demonstrate that there were no non-specific reactions. Only the pigmentation of the iris in iris pigment epithelium (brown
colour) is seen, with a counterstaining with Mayer’s haematoxylin and eosin showing a discrete nuclear pattern.
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marker for high endothelial venules, gave posi-
tive staining results in three out of seven irises
from patients with uveitis.
ADHESION MOLECULE EXPRESSION IN GLAUCOMA
PATIENTS
In two iris biopsy specimens from patients with
glaucoma, adhesion molecules were expressed;
ICAM-1 and VCAM-1 were expressed on vas-
cular endothelium, iris resident cells, and on a
few scattered infiltrating mononuclear cells.
LFA-1á/â was only weakly expressed on some
of these mononuclear cells.
Discussion
We found a statistical significant increase in the
expression of the adhesion molecules ICAM-1,
LFA-1, and VCAM-1 in the iris of patients
with uveitis compared with controls (patients
with glaucoma). However, one has to keep in
mind that when a correction is applied for
multiple comparisons, all p values presented in
Table 2 should be multiplied with a factor
associated with the number of comparisons
made and the sample size. Therefore, owing to
the small number of iris biopsies some
diVerences in adhesion molecule expression
were not statistically significant in this study.
For example, the difference in VCAM-1
expression (36% v 25%), HECA-452 (43% v
12.5%), and LFA-1á (45% v 12.5%) may have
become statistically significant with a larger
number of iris biopsies (Table 2).
ICAM-1 was expressed in a significantly
higher number of iris biopsy specimens from
patients with uveitis than in controls. This cor-
responds with earlier studies.11 12 It seems likely
that ICAM-1, expressed at low levels on
normal endothelium, has been upregulated by
chemokines or cytokines. IL-1, TNF-á, and
IFN-ã are known to play a specific role in the
upregulation of these ICAM-1 molecules.
LFA-1á was also found in a high number of
iris biopsies from patients with uveitis, but only
reached statistical significance on the popula-
tion of iris resident cells. A striking diVerence
was found between the expression of LFA-1á
(áL integrin subunit) and LFA-1â (â2 integrin
subunit). Perhaps in patients with uveitis, this á
subunit is associated with a diVerent, yet
unknown, â chain.
VCAM-1, of which no earlier studies investi-
gated the expression in the iris of patients with
uveitis, was found in a significantly higher
number of iris biopsies from patients with
uveitis than in controls. This points to an acti-
vated endothelial state and perhaps a role for
IL-1, TNF-á, or IL-4, which are all capable of
inducing this adhesion molecule. Moreover,
VCAM-1 plays a prominent role in lymphocyte
recruitment to sites of inflammation and can
be activated by antigen presenting cells.20
VLA-4 (á4 subunit), the VCAM-1 counter-
receptor, was found in only one iris biopsy
specimen from a patient with uveitis. This is a
score somewhat below expectations, because
VLA-4 is also the counterreceptor for fibronec-
tin, which has been reported earlier to be
present in the iris of a majority of patients with
uveitis.3 However, one has to keep in mind that
the absence of VLA-4, which is a late activation
marker of T cells, in our iris biopsies was per-
haps not surprising since all iris biopsies were
obtained in a quiet phase of the disease.
LECAM was not detected in the iris of
patients with uveitis. This may be explained by
the fact that LECAM (L selectin) is thought to
be involved in the initial steps of the adhesion
cascade, and all iris biopsy specimens were
obtained from patients with a quiescent uveitis,
usually with a disease duration of 5–10 years.
Moreover, L selectin (LECAM) is shed after
activation by protean cleavage near the mem-
brane insertion.6 This cleavage has been specu-
lated to be a mechanism by which lymphocyte
traYcking and transmigration are modulated,
producing an attenuation of the immune
response.6 Furthermore, it has recently been
demonstrated that various NSAIDs such as
indomethacin, ketoprofen, or diclofenac are
capable of preventing leucocyte/endothelial
cell interaction through the specific eVect of
inducing L selectin loss by endothelial cells.23
HECA-452, a marker for specialised high
endothelial venules (HEV),21 was detected on
endothelial cells in the iris of three patients
with uveitis, although these venules showed no
characteristic morphological changes. Wake-
field et al,11 however, did report the morpho-
logical appearance of HEV in some of the iris
biopsy specimens from their series of patients
with uveitis. It is an interesting finding, since
HECA-452 is a homing receptor for lym-
phocytes, and it supports the idea that the eye
is capable of processes by which T cells may
home to the eye, and it supports its role as an
immunocompetent site.
One has to keep in mind, however, that iris
biopsy specimens were obtained in a quiet
phase of the uveitis in all cases. It may be
expected that the expression of adhesion
molecules is elevated during the active stages of
disease, and perhaps even a diVerent profile of
adhesion molecule expression may then be
found. Furthermore, the expression of adhe-
sion molecules in the iris of patients with uvei-
tis may be strongly influenced by the fact that
most of these patients were treated with local
steroids for some time. Corticosteroids have
been demonstrated to decrease the expression
of adhesion molecules like E selectin and
ICAM-1 on stimulated endothelium.24
In our study a higher number of control
specimens showed an expression of adhesion
molecules than in earlier studies.11 12 This may
be due to the fact that our control population
consisted of iris biopsies from patients with
glaucoma treated with local antiglaucoma
therapy, rather than normal eye bank eyes12 or
patients with cataract11 who never had any local
therapy. Patients with glaucoma cannot en-
tirely be regarded as “normal” controls, as ear-
lier studies and also the current study, reported
the presence of scattered infiltrating lym-
phocytes in the iris of these patients.2 3
In our previous study on iris biopsy specimens
from patients with uveitis25 we found a typical
deposition of immunoglobulins and complem-
ent in the vessel walls of the iris and not in the
surrounding tissue, strongly suggesting a
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peripheral blood origin of these immune
deposits. Conditions in the endothelial wall of
the iris vessels of patients with uveitis may
therefore be altered and have an immunoregu-
latory function. The expression of adhesion
molecules on (activated) endothelium found in
our current study supports this idea, and
suggests the involvement of iris vascular
endothelial cells in rolling, adhesion, and
transmigration of circulating lymphocytes into
the inflamed site in a tissue specific manner.
One can, however, not exclude the possibility
that the increased expression of adhesion mole-
cules on endothelium in uveitis patients is a
non-specific response.
Several therapies that modulate the expres-
sion of adhesion molecules have been proposed
and some of them have already been carried
out in animal models26: (1) the use of receptor
specific monoclonal antibodies, (2) oligonucle-
otide based therapies that inhibit the transcrip-
tion or translation of the adhesion receptor
mRNA, (3) small synthetic peptides or peptide
analogues that resemble cell ligands and are
capable of blocking adhesion receptors, and
(4) cytokine directed therapies that decrease
the upregulation of adhesion receptors. In ani-
mal models with uveitis injections with mono-
clonal antibodies against ICAM-1 or LFA-1
resulted in a significant decrease of ocular
inflammation.15 27 28
In conclusion, an increased expression of
adhesion molecules in the iris of patients with
uveitis was found. However, no specific pattern
or combination of expression of adhesion mol-
ecules could be detected. Perhaps other, yet
unidentified adhesion molecules, specific for
the iris, alone or in combination with the adhe-
sion molecules studied here, dictate a tissue
specific target for T cells entering the inflamed
iris from the circulation. Future studies,
preferably in more active stages of the disease,
are necessary to search for such iris specific
adhesion molecule(s), of which the expression
seems obligatory, since the eye is known to be
an immunologically privileged site.
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